New rotating catheter aims to unclog leg arteries without major surgery

NCT ID NCT07016698

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is tracking 600 people with peripheral artery disease (PAD) who are treated with the Rotarex device, a rotating catheter that cuts and removes plaque from blocked leg arteries. The goal is to see how well the device restores blood flow and how often serious complications occur within 30 days. Participants must have blockages in the leg arteries suitable for the device and be at least 22 years old.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Rotarex rotational excisional atherectomy system (a device that cuts and removes plaque from leg arteries)
What this could lead to
If successful, this registry could confirm that the Rotarex device is a safe and effective option for restoring blood flow in leg arteries, helping people with peripheral artery disease avoid more invasive surgery.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the device is better than other treatments. Results may not apply to all patients, and risks include artery damage, bleeding, or the need for repeat procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE (PAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Radiology and Imaging Specialists

    RECRUITING

    Lakeland, Florida, 33805, United States

  • Vital Heart and Vein

    RECRUITING

    Humble, Texas, 77338, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.